Abstract
Orthotopic liver transplantation (OLT) offers the best chance for cure in the setting of unresectable hepatocellular carcinoma (HCC). A consensus statement recommends locoregional therapy (LRT) be considered in patients with HCC who are expected to wait more than 6 months for OLT to diminish dropout from the waiting list because of tumor progression. This article reviews LRT as a bridge to OLT in patients with HCC.
Original language | English (US) |
---|---|
Pages (from-to) | 1183-1191 |
Number of pages | 9 |
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 12 |
Issue number | 8 |
DOIs | |
State | Published - Aug 1 2014 |
ASJC Scopus subject areas
- Oncology